Delavirdine - PDFSEARCH.IO - Document Search Engine

Delavirdine
Results: 36

#	Item
21	GlaxoSmithKline PO Box[removed]Five Moore Drive Research Triangle Park North Carolina[removed]www.gsk.com Add to Reading List Source URL: www.fda.gov Language: English Carbamates Sulfonamides Alcohols Amides Antiretroviral drug Lopinavir/ritonavir Fosamprenavir Delavirdine Zidovudine Chemistry Organic chemistry Protease inhibitors
22	Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-08-21 18:06:39 Sulfonamides Carbamates Bristol-Myers Squibb Organochlorides Ritonavir Itraconazole Efavirenz Delavirdine Dofetilide Chemistry Organic chemistry Protease inhibitors
23	Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart lists recommendations for new/updated edits for consideration by the Drug Mana Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-08-21 16:57:18 Pfizer Sulfonamides Carbamates Piperazines Ritonavir Delavirdine Dofetilide Itraconazole Simvastatin Chemistry Organic chemistry Protease inhibitors
24	----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-02-14 16:20:44 Ritonavir Lopinavir Delavirdine Nelfinavir Antiretroviral drug Fosamprenavir Darunavir Atazanavir Protease inhibitors Chemistry Organic chemistry
25	Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-08-21 13:53:03 Sulfonamides Protease inhibitors Carbamates Non-nucleoside reverse transcriptase inhibitors Ritonavir Delavirdine Efavirenz Dofetilide Itraconazole Chemistry Organic chemistry Pfizer
26	Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-08-21 13:36:45 Sulfonamides Carbamates Bristol-Myers Squibb Organochlorides Ritonavir Itraconazole Efavirenz Delavirdine Dofetilide Chemistry Organic chemistry Protease inhibitors
27	----------------------- WARNINGS AND PRECAUTIONS ---------------  Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1)  LEXIVA should be dis Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-02-22 15:55:20 Ritonavir Lopinavir Delavirdine Antiretroviral drug Nelfinavir Darunavir Lopinavir/ritonavir Protease inhibitors Chemistry Organic chemistry
28	etravirine – [removed]Final Labeling Text HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE™ safely and effectively. See full prescribing information for Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-10-06 17:32:52 Etravirine Ritonavir Darunavir Lopinavir/ritonavir Atazanavir Tibotec Antiretroviral drug Delavirdine Saquinavir Chemistry Organic chemistry Protease inhibitors
29	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD[removed]ATTENTION PHARMACIST: Detach "Patient’s Instructions for Use” from package Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:57:04 Tipranavir Ritonavir Saquinavir Lopinavir Atazanavir Antiretroviral drug Enfuvirtide Fluoride Delavirdine Chemistry Protease inhibitors Organic chemistry
30	• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-05-16 15:11:05 Ritonavir Lopinavir Delavirdine Nelfinavir Antiretroviral drug Darunavir Fosamprenavir Lopinavir/ritonavir Protease inhibitors Chemistry Organic chemistry